Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Eastham

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Endocrinology|December 1, 1999
Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostateR M Adam, J G Borer, J Williams, et al.
British Journal of Urology|March 1, 1996
Impalpable prostate cancer: clinicopathological featuresE Rogers, J A Eastham, M Ohori, et al.
Urology|November 24, 1999
Race is not an independent predictor of positive surgical margins after radical prostatectomyM N Witte, M W Kattan, J Albani, et al.
The Journal of Urology|November 1, 1994
Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?M Ohori, J R Goad, T M Wheeler, et al.
The Journal of Urology|October 23, 1997
Influence of hepatic function on serum levels of prostate specific antigenP B Williams, J A Eastham, D J Culkin, et al.
Prostate Cancer and Prostatic Diseases|December 17, 2014
The diffusion of minimally invasive radical prostatectomy in the United States: a case study of the introduction of new surgical devicesC B Anderson, E B Elkin, C L Atoria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancerJ A Eastham, M W Kattan, S Groshen, et al.
The Journal of Urology|November 1, 1996
Risk factors for urinary incontinence after radical prostatectomyJ A Eastham, M W Kattan, E Rogers, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1995
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancerJ A Eastham, L D Truong, E Rogers, et al.
Journal of the National Cancer Institute|January 15, 1997
Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancerR J Henderson, J A Eastham, D J Culkin, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Endocrinology|December 1, 1999
Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostateR M Adam, J G Borer, J Williams, et al.
British Journal of Urology|March 1, 1996
Impalpable prostate cancer: clinicopathological featuresE Rogers, J A Eastham, M Ohori, et al.
Urology|November 24, 1999
Race is not an independent predictor of positive surgical margins after radical prostatectomyM N Witte, M W Kattan, J Albani, et al.
The Journal of Urology|November 1, 1994
Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?M Ohori, J R Goad, T M Wheeler, et al.
The Journal of Urology|October 23, 1997
Influence of hepatic function on serum levels of prostate specific antigenP B Williams, J A Eastham, D J Culkin, et al.
Prostate Cancer and Prostatic Diseases|December 17, 2014
The diffusion of minimally invasive radical prostatectomy in the United States: a case study of the introduction of new surgical devicesC B Anderson, E B Elkin, C L Atoria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancerJ A Eastham, M W Kattan, S Groshen, et al.
The Journal of Urology|November 1, 1996
Risk factors for urinary incontinence after radical prostatectomyJ A Eastham, M W Kattan, E Rogers, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1995
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancerJ A Eastham, L D Truong, E Rogers, et al.
Journal of the National Cancer Institute|January 15, 1997
Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancerR J Henderson, J A Eastham, D J Culkin, et al.
Pageof 6